Seikagaku Kogyo Kabushiki Kaisha

ARTZ

pharmaceuticals for the treatment of osteoarthritis and periarthritis;

ARUSTAK

Pharmaceutical products in gel state for the treatment of joint disease; injection syringe containing cross-linked hyaluronic acid gel for the treatment of joint disease;The wording ARUSTAK has no meaning in a foreign language.;

BIMCROSS

pharmaceutical preparations, namely, biopolymers for reducing or preventing adhesions during or after surgery;surgical devices, namely, hydrogel inserts used on the human body, tissues and organs to prevent adhesions during or after surgery;

CHONDRYSE

pharmaceutical preparations for the treatment of herniated intervertebral discs;

CHONDRYSE

pharmaceutical preparations for the treatment of herniated lumbar intervertebral discs; pharmaceutical preparations for the treatment of spinal cord injuries, damaged nerves and nerve, nervous or neurological diseases or disorders; pharmaceutical preparations for the treatment of ophthalmic diseases;

CYSCOAT

Pharmaceutical preparations for treatment of cystitis;CYSTITIS COAT;

CYSPARTZ

Pharmaceutical preparations for treatment of cystitis;CYSTITIS PARTS;

CYSTALL

Pharmaceutical preparations for treatment of cystitis;

CYSTOCARE

PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF CYSTITIS;

GEL-ARTZ

Pharmaceutical products in gel state for the treatment of joint disease; Injection syringe containing cross-linked hyaluronic acid gel;GEL-ARTS;

GEL-ONE

Pharmaceutical products in gel state for the treatment of joint disease; Injection syringe containing cross-linked hyaluronic acid gel for medical use;

GEL-ONE

(Based on 44(e)) (Based on Use in Commerce) Pre-filled syringes containing pharmaceutical preparations for injection into the joints for use in the treatment of osteoarthritis, articular disorders and pains due to thereof; injectable intra-articular applicators, namely, syringes containing pharmaceutical preparations used as a viscosupplement for medical use; medical apparatus, namely, pre-filled syringes containing injectable pharmaceutical preparations based on hyaluronate; Intra-articular injectors containing preparations based on hyaluronate for medical use;(Based on 44(e)) Medical syringes; Injection syringes;

GELIBEX

Pharmaceutical products in gel state for the treatment of joint disease; injection syringe containing cross-linked hyaluronic acid gel for the treatment of joint disease;The wording GELIBEX has no meaning in a foreign language.;

GELIEF

Pharmaceutical products in gel state for the treatment of joint disease; injection syringe containing cross-linked hyaluronic acid gel for the treatment of joint disease;GEL RELIEF;The wording GELIEF has no meaning in a foreign language.;

GELLINX

Pharmaceutical products in gel state for the treatment of joint disease; injection syringe containing cross-linked hyaluronic acid gel for the treatment of joint disease;GEL LINKS;The wording GELLINX has no meaning in a foreign language.;

GELMIRA

Pharmaceutical products in gel state for the treatment of joint disease; injection syringe containing cross-linked hyaluronic acid gel for the treatment of joint disease;The wording GELMIRA has no meaning in a foreign language.;

GELNAMIC

Pharmaceutical products in gel state for the treatment of joint disease; injection syringe containing cross-linked hyaluronic acid gel for the treatment of joint disease;GEL DYNAMIC;The wording GELNAMIC has no meaning in a foreign language.;

GELTRESA

Pharmaceutical products in gel state for the treatment of joint disease; injection syringe containing cross-linked hyaluronic acid gel for the treatment of joint disease;The wording GELTRESA has no meaning in a foreign language.;

GLYCOFORUM

EDUCATIONAL SERVICES, namely, [ PLANNING, MANAGING AND ] PROMOTING SEMINARS, [ PRESENTATION OF RESEARCH PAPERS AND SYMPOSIA ] IN THE FIELD OF [ GLYOSCIENCE ] * GLYCOSCIENCE *;In the statement, Column 1, line 10, GLYOSCIENCE should be deleted, and, GLYCOSCIENCE should be inserted. In the statement, Column 2, line 2, GLYCOSCIENE should be deleted, and, GLYCOSCIENCE should be inserted.;GLYCO FORUM;Color is not claimed as a feature of the mark.;PROVISION OF INFORMATION FOR PUBLIC REFERENCE RELATING TO GLYCOSCIENCE PROVIDED VIA ON-LINE DATABASE; PROVISION OF INFORMATION RELATING TO [ GLYCOSCIENE ] * GLYCOSCIENCE * PROVIDED VIA COMPUTER NETWORK;

HERNICORE

The mark consists of the word HERNICORE in upper case, stylized letters.;Pharmaceutical preparations for the treatment of lumbar disc herniation;